CymaBay Therapeutics, Inc. 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 23, 2017
Insider Transaction Report
Form 4
Weiland Robert J.
Director
Transactions
- Award
Stock Option (right to buy)
2017-01-19+12,000→ 12,000 totalExercise: $1.72Exp: 2027-01-18→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The option vests in three annual installments from the vesting start date of January 19, 2017.